Innovative research and therapeutic applications require collaborative efforts to become reality. Lentigen and its parent company Miltenyi Biotec have a long and successful history in implementing new technologies for clinical research and cell and gene therapy applications.
If you are interested in
innovative approaches to cellular engineering with lentiviral vectors
optimizing transduction and transgene expression
bringing immunotherapy and gene therapy approaches into clinical reality
please contact us to discuss opportunities for scientific collaboration including and beyond lentiviral vector development and manufacturing.